West Pharmaceutical Services, Inc. (WST)
USD 211.29
(0.49%)
USD 211.29
(0.49%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 593.4 Million USD | 1.28% |
| 2022 | 585.9 Million USD | -11.47% |
| 2021 | 661.8 Million USD | 91.16% |
| 2020 | 346.2 Million USD | 43.24% |
| 2019 | 241.7 Million USD | 16.82% |
| 2018 | 206.9 Million USD | 37.29% |
| 2017 | 150.7 Million USD | 4.94% |
| 2016 | 143.6 Million USD | 50.21% |
| 2015 | 95.6 Million USD | -24.78% |
| 2014 | 127.1 Million USD | 13.18% |
| 2013 | 112.3 Million USD | 39.16% |
| 2012 | 80.7 Million USD | 6.89% |
| 2011 | 75.5 Million USD | 15.62% |
| 2010 | 65.3 Million USD | -10.06% |
| 2009 | 72.6 Million USD | -15.58% |
| 2008 | 86 Million USD | 21.64% |
| 2007 | 70.7 Million USD | 5.37% |
| 2006 | 67.1 Million USD | 47.15% |
| 2005 | 45.6 Million USD | 135.05% |
| 2004 | 19.4 Million USD | -39.18% |
| 2003 | 31.9 Million USD | 73.37% |
| 2002 | 18.4 Million USD | 453.85% |
| 2001 | -5.2 Million USD | -425.0% |
| 2000 | 1.6 Million USD | -95.87% |
| 1999 | 38.7 Million USD | 477.61% |
| 1998 | 6.7 Million USD | -84.91% |
| 1997 | 44.4 Million USD | 170.73% |
| 1996 | 16.4 Million USD | -42.86% |
| 1995 | 28.7 Million USD | 5.13% |
| 1994 | 27.3 Million USD | 16.17% |
| 1993 | 23.5 Million USD | 19.29% |
| 1992 | 19.7 Million USD | 331.76% |
| 1991 | -8.5 Million USD | -297.67% |
| 1990 | 4.3 Million USD | -79.23% |
| 1989 | 20.7 Million USD | 18.97% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 111.3 Million USD | -3.47% |
| 2024 Q3 | 136 Million USD | 22.19% |
| 2024 Q1 | 115.3 Million USD | -15.84% |
| 2023 Q2 | 155.1 Million USD | 10.79% |
| 2023 Q1 | 140 Million USD | 35.92% |
| 2023 FY | 593.4 Million USD | 1.28% |
| 2023 Q3 | 161.3 Million USD | 4.0% |
| 2023 Q4 | 137 Million USD | -15.07% |
| 2022 Q2 | 188.5 Million USD | 8.46% |
| 2022 FY | 585.9 Million USD | -11.47% |
| 2022 Q1 | 173.8 Million USD | 17.67% |
| 2022 Q4 | 103 Million USD | -14.59% |
| 2022 Q3 | 120.6 Million USD | -36.02% |
| 2021 Q4 | 147.7 Million USD | -15.89% |
| 2021 FY | 661.8 Million USD | 91.16% |
| 2021 Q1 | 151.2 Million USD | 53.66% |
| 2021 Q2 | 187.3 Million USD | 23.88% |
| 2021 Q3 | 175.6 Million USD | -6.25% |
| 2020 FY | 346.2 Million USD | 43.24% |
| 2020 Q2 | 91.2 Million USD | 22.75% |
| 2020 Q1 | 74.3 Million USD | 16.28% |
| 2020 Q3 | 82.3 Million USD | -9.76% |
| 2020 Q4 | 98.4 Million USD | 19.56% |
| 2019 Q2 | 66.1 Million USD | 19.31% |
| 2019 Q1 | 55.4 Million USD | 6.54% |
| 2019 Q3 | 56.3 Million USD | -14.83% |
| 2019 Q4 | 63.9 Million USD | 13.5% |
| 2019 FY | 241.7 Million USD | 16.82% |
| 2018 Q4 | 52 Million USD | -5.8% |
| 2018 Q1 | 43.6 Million USD | 1844.0% |
| 2018 Q2 | 56.1 Million USD | 28.67% |
| 2018 Q3 | 55.2 Million USD | -1.6% |
| 2018 FY | 206.9 Million USD | 37.29% |
| 2017 Q2 | 38.8 Million USD | -36.29% |
| 2017 Q1 | 60.9 Million USD | 55.75% |
| 2017 Q3 | 51 Million USD | 31.44% |
| 2017 Q4 | -2.5 Million USD | -104.9% |
| 2017 FY | 150.7 Million USD | 4.94% |
| 2016 Q2 | 44.7 Million USD | 102.26% |
| 2016 FY | 143.6 Million USD | 50.21% |
| 2016 Q3 | 37.6 Million USD | -15.88% |
| 2016 Q1 | 22.1 Million USD | -33.83% |
| 2016 Q4 | 39.1 Million USD | 3.99% |
| 2015 Q1 | 32.9 Million USD | 4.78% |
| 2015 FY | 95.6 Million USD | -24.78% |
| 2015 Q2 | 27.8 Million USD | -15.5% |
| 2015 Q3 | 1.5 Million USD | -94.6% |
| 2015 Q4 | 33.4 Million USD | 2126.67% |
| 2014 Q3 | 31 Million USD | -17.55% |
| 2014 FY | 127.1 Million USD | 13.18% |
| 2014 Q1 | 27.1 Million USD | 14.83% |
| 2014 Q2 | 37.6 Million USD | 38.75% |
| 2014 Q4 | 31.4 Million USD | 1.29% |
| 2013 Q3 | 26.8 Million USD | -11.26% |
| 2013 FY | 112.3 Million USD | 39.16% |
| 2013 Q4 | 23.6 Million USD | -11.94% |
| 2013 Q2 | 30.2 Million USD | -4.73% |
| 2013 Q1 | 31.7 Million USD | 50.24% |
| 2012 Q1 | 29.2 Million USD | 55.32% |
| 2012 FY | 80.7 Million USD | 6.89% |
| 2012 Q2 | 15.6 Million USD | -46.58% |
| 2012 Q4 | 21.1 Million USD | 42.57% |
| 2012 Q3 | 14.8 Million USD | -5.13% |
| 2011 FY | 75.5 Million USD | 15.62% |
| 2011 Q1 | 19.6 Million USD | 226.67% |
| 2011 Q2 | 20.1 Million USD | 2.55% |
| 2011 Q3 | 16.9 Million USD | -15.92% |
| 2011 Q4 | 18.8 Million USD | 11.24% |
| 2010 Q1 | 19.8 Million USD | -2.46% |
| 2010 FY | 65.3 Million USD | -10.06% |
| 2010 Q4 | 6 Million USD | -66.29% |
| 2010 Q3 | 17.8 Million USD | -17.97% |
| 2010 Q2 | 21.7 Million USD | 9.6% |
| 2009 Q3 | 17.2 Million USD | -12.69% |
| 2009 Q4 | 20.3 Million USD | 18.02% |
| 2009 FY | 72.6 Million USD | -15.58% |
| 2009 Q2 | 19.7 Million USD | 27.92% |
| 2009 Q1 | 15.4 Million USD | -12.99% |
| 2008 Q3 | 13.3 Million USD | -53.66% |
| 2008 Q4 | 17.7 Million USD | 33.08% |
| 2008 Q1 | 26.2 Million USD | 336.67% |
| 2008 FY | 86 Million USD | 21.64% |
| 2008 Q2 | 28.7 Million USD | 9.54% |
| 2007 Q2 | 26 Million USD | -1.89% |
| 2007 Q4 | 6 Million USD | -50.82% |
| 2007 Q1 | 26.5 Million USD | 76.67% |
| 2007 FY | 70.7 Million USD | 5.37% |
| 2007 Q3 | 12.2 Million USD | -53.08% |
| 2006 Q4 | 15 Million USD | 12.78% |
| 2006 Q1 | 18.1 Million USD | 54.7% |
| 2006 FY | 67.1 Million USD | 47.15% |
| 2006 Q2 | 20.7 Million USD | 14.36% |
| 2006 Q3 | 13.3 Million USD | -35.75% |
| 2005 Q3 | 7.8 Million USD | -39.06% |
| 2005 FY | 45.6 Million USD | 135.05% |
| 2005 Q4 | 11.7 Million USD | 50.0% |
| 2005 Q2 | 12.8 Million USD | -3.76% |
| 2005 Q1 | 13.3 Million USD | 3225.0% |
| 2004 Q3 | 4.3 Million USD | -44.16% |
| 2004 FY | 19.4 Million USD | -39.18% |
| 2004 Q2 | 7.7 Million USD | 10.0% |
| 2004 Q4 | 400 Thousand USD | -90.7% |
| 2004 Q1 | 7 Million USD | -59.06% |
| 2003 Q3 | 4.1 Million USD | -40.58% |
| 2003 FY | 31.9 Million USD | 73.37% |
| 2003 Q2 | 6.9 Million USD | 81.58% |
| 2003 Q1 | 3.8 Million USD | 11.76% |
| 2003 Q4 | 17.1 Million USD | 317.07% |
| 2002 Q3 | 3.6 Million USD | -32.08% |
| 2002 FY | 18.4 Million USD | 453.85% |
| 2002 Q1 | 6.1 Million USD | 131.12% |
| 2002 Q2 | 5.3 Million USD | -13.11% |
| 2002 Q4 | 3.4 Million USD | -5.56% |
| 2001 Q3 | 5.9 Million USD | 90.32% |
| 2001 Q4 | -19.6 Million USD | -432.2% |
| 2001 Q1 | 5.4 Million USD | 141.22% |
| 2001 Q2 | 3.1 Million USD | -42.59% |
| 2001 FY | -5.2 Million USD | -425.0% |
| 2000 Q3 | 4.6 Million USD | -8.0% |
| 2000 Q1 | 5.1 Million USD | -50.0% |
| 2000 FY | 1.6 Million USD | -95.87% |
| 2000 Q2 | 5 Million USD | -1.96% |
| 2000 Q4 | -13.1 Million USD | -384.78% |
| 1999 Q4 | 10.2 Million USD | 18.6% |
| 1999 Q1 | 9.5 Million USD | -5.0% |
| 1999 Q2 | 10.4 Million USD | 9.47% |
| 1999 Q3 | 8.6 Million USD | -17.31% |
| 1999 FY | 38.7 Million USD | 477.61% |
| 1998 Q4 | 10 Million USD | 53.85% |
| 1998 Q3 | 6.5 Million USD | -34.34% |
| 1998 FY | 6.7 Million USD | -84.91% |
| 1998 Q1 | -19.7 Million USD | -329.07% |
| 1998 Q2 | 9.9 Million USD | 150.25% |
| 1997 Q3 | 17.3 Million USD | 71.29% |
| 1997 FY | 44.4 Million USD | 170.73% |
| 1997 Q1 | 8.4 Million USD | -15.15% |
| 1997 Q2 | 10.1 Million USD | 20.24% |
| 1997 Q4 | 8.6 Million USD | -50.29% |
| 1996 Q1 | -8.2 Million USD | -203.8% |
| 1996 Q3 | 6.6 Million USD | -18.52% |
| 1996 Q4 | 9.9 Million USD | 50.0% |
| 1996 FY | 16.4 Million USD | -42.86% |
| 1996 Q2 | 8.1 Million USD | 198.78% |
| 1995 Q3 | 3.9 Million USD | -55.17% |
| 1995 Q1 | 8.2 Million USD | 13.89% |
| 1995 Q2 | 8.7 Million USD | 6.1% |
| 1995 Q4 | 7.9 Million USD | 102.56% |
| 1995 FY | 28.7 Million USD | 5.13% |
| 1994 Q3 | 5.6 Million USD | -25.33% |
| 1994 Q4 | 7.2 Million USD | 28.57% |
| 1994 FY | 27.3 Million USD | 16.17% |
| 1994 Q1 | 7 Million USD | 18.64% |
| 1994 Q2 | 7.5 Million USD | 7.14% |
| 1993 FY | 23.5 Million USD | 19.29% |
| 1993 Q1 | 6.6 Million USD | 50.0% |
| 1993 Q2 | 6.2 Million USD | -6.06% |
| 1993 Q3 | 4.8 Million USD | -22.58% |
| 1993 Q4 | 5.9 Million USD | 22.92% |
| 1992 FY | 19.7 Million USD | 331.76% |
| 1992 Q4 | 4.4 Million USD | 7.32% |
| 1992 Q3 | 4.1 Million USD | -26.79% |
| 1992 Q2 | 5.6 Million USD | 0.0% |
| 1992 Q1 | 5.6 Million USD | 130.27% |
| 1991 Q3 | 2.3 Million USD | -34.29% |
| 1991 Q2 | 3.5 Million USD | -14.63% |
| 1991 Q1 | 4.1 Million USD | 169.49% |
| 1991 FY | -8.5 Million USD | -297.67% |
| 1991 Q4 | -18.5 Million USD | -904.35% |
| 1990 Q4 | -5.9 Million USD | -447.06% |
| 1990 Q1 | 5.6 Million USD | 0.0% |
| 1990 FY | 4.3 Million USD | -79.23% |
| 1990 Q3 | 1.7 Million USD | -41.38% |
| 1990 Q2 | 2.9 Million USD | -48.21% |
| 1989 FY | 20.7 Million USD | 18.97% |
| 1989 Q2 | - USD | 0.0% |
| 1989 Q1 | - USD | 0.0% |
| 1989 Q3 | - USD | 0.0% |
| 1989 Q4 | - USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Alcon Inc. | 974 Million USD | 39.076% |
| AptarGroup, Inc. | 284.48 Million USD | -108.586% |
| Baxter International Inc. | 2.65 Billion USD | 77.658% |
| Becton, Dickinson and Company | 1.72 Billion USD | 65.62% |
| Bausch + Lomb Corporation | -260 Million USD | 328.231% |
| Haemonetics Corporation | 117.55 Million USD | -404.772% |
| Envista Holdings Corp | -100.2 Million USD | 692.216% |
| ResMed Inc. | 1.02 Billion USD | 41.878% |
| Teleflex Incorporated | 356.32 Million USD | -66.532% |
| Warby Parker Inc. | -63.19 Million USD | 1038.969% |